Antibiotic dosing to prevent pneumonia after brain injury
Part of Brain & nervous system, Infections, Injuries & trauma, Lungs & breathing clinical trials.
This trial studies how a common antibiotic (ceftriaxone) is processed in the body of brain-injured patients on breathing machines, to find the best dose for preventing early pneumonia. It may help improve care and outcomes for people with serious brain injuries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are in the intensive care unit (ICU) with a recent brain injury, such as a traumatic brain injury or a stroke
- Your level of consciousness is low (Glasgow coma scale less than 12)
- You needed a breathing tube placed within 12 hours of being admitted to the ICU
- You are expected to need a breathing machine (ventilator) for at least 48 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving an antibiotic (ceftriaxone) early after a severe brain injury can prevent lung infections caused by the breathing machine (ventilator). It is for adults in the ICU who recently started on a ventilator due to a brain emergency.
This study monitors the amount of certain antibiotics in the blood of patients with acute brain injury in the intensive care unit. It aims to make sure the antibiotics are at the right level to fight infection, especially in patients whose kidneys are clearing drugs faster than normal.
This study is testing whether a certain dose of ceftriaxone, an antibiotic given intravenously, works well for people with pneumonia who are not severely ill. Participation could help doctors find the best dose for treating pneumonia without needing intensive care.
This trial tests whether giving an inhaled antibiotic called colistin can prevent pneumonia in patients with brain injuries who are on ventilators. If effective, it could reduce lung infections and improve recovery.
This trial tests whether using non-invasive suctioning methods (without needing to disconnect the breathing tube) can lower the risk of lung infections in critically ill patients who need a breathing tube. It may help reduce the chance of pneumonia during intensive care.
This study tests whether giving inhaled antibiotics based on a patient's own airway bacteria can prevent ventilator-associated pneumonia (a lung infection from the breathing tube) in intensive care patients. It may help reduce infections in people who need a breathing tube for more than three days.
Hear when a new Early Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.